Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Treatment of intracranial vertebral artery dissecting aneurysms involving the posterior inferior cerebellar artery origin.

Chen JA, Garrett MC, Mlikotic A, Ausman JI.

Surg Neurol Int. 2019 Jun 25;10:116. doi: 10.25259/SNI-281-2019. eCollection 2019.

2.

Difficult case of a rare form of familial Alzheimer's disease with PSEN1 P117L mutation.

Rocha AL, Costa A, Garrett MC, Meireles J.

BMJ Case Rep. 2018 Dec 13;11(1). pii: e226664. doi: 10.1136/bcr-2018-226664.

PMID:
30567237
3.

Large-scale assessment of the gliomasphere model system.

Laks DR, Crisman TJ, Shih MY, Mottahedeh J, Gao F, Sperry J, Garrett MC, Yong WH, Cloughesy TF, Liau LM, Lai A, Coppola G, Kornblum HI.

Neuro Oncol. 2016 Oct;18(10):1367-78. doi: 10.1093/neuonc/now045. Epub 2016 Apr 25.

4.

Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma.

Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM.

Neuro Oncol. 2016 Mar;18(3):368-78. doi: 10.1093/neuonc/nov153. Epub 2015 Sep 1.

5.

Superficial siderosis of the central nervous system.

Sampaio L, Aires A, Garrett MC, Pinto M.

BMJ Case Rep. 2015 Aug 3;2015. pii: bcr2015211957. doi: 10.1136/bcr-2015-211957. No abstract available.

6.

Integrating risk management data in quality improvement initiatives within an academic neurosurgery department.

McLaughlin N, Garrett MC, Emami L, Foss SK, Klohn JL, Martin NA.

J Neurosurg. 2016 Jan;124(1):199-206. doi: 10.3171/2014.11.JNS132653. Epub 2015 Jul 31.

PMID:
26230469
7.

Complex ophthalmoplaegia denoting Wernicke encephalopathy in a non-alcoholic individual.

Aires A, Filipe JP, Garrett MC, Real R.

BMJ Case Rep. 2015 Mar 31;2015. pii: bcr2014207284. doi: 10.1136/bcr-2014-207284. No abstract available.

8.

Isolated III cranial nerve palsy: a Hodgkin's lymphoma?

Meireles J, Garrett MC, Abreu P.

BMJ Case Rep. 2014 Apr 23;2014. pii: bcr2014203999. doi: 10.1136/bcr-2014-203999.

9.

An evidence-based approach to the efficient use of computed tomography imaging in the neurosurgical patient.

Garrett MC, Bilgin-Freiert A, Bartels C, Everson R, Afsarmanesh N, Pouratian N.

Neurosurgery. 2013 Aug;73(2):209-15; discussion 215-6. doi: 10.1227/01.neu.0000430328.25516.dd.

10.

Reversible parkinsonism due to a large intracranial tumour.

Rocha H, Cerejo A, Garrett MC, Massano J.

BMJ Case Rep. 2012 Dec 23;2012. pii: bcr2012007823. doi: 10.1136/bcr-2012-007823.

11.

Stretching the limbs? Tonic spasms in multiple sclerosis.

Andrade C, Massano J, Guimarães J, Garrett MC.

BMJ Case Rep. 2012 Nov 30;2012. pii: bcr2012007513. doi: 10.1136/bcr-2012-007513.

12.

Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.

Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, Mottahedeh J, Nghiemphu PL, Kornblum HI, Mischel PS, Prins RM, Yong WH, Cloughesy T, Nelson SF, Liau LM, Lai A.

J Natl Cancer Inst. 2012 Oct 3;104(19):1458-69. doi: 10.1093/jnci/djs357. Epub 2012 Sep 3.

13.

Use of language mapping to aid in resection of gliomas in eloquent brain regions.

Garrett MC, Pouratian N, Liau LM.

Neurosurg Clin N Am. 2012 Jul;23(3):497-506. doi: 10.1016/j.nec.2012.05.003. Review.

14.

The role of breast MRI in the investigation of anti-Yo positive paraneoplastic cerebellar degeneration.

Real R, Oliveira A, Nadais G, Loureiro J, Garrett MC.

BMJ Case Rep. 2012 Mar 27;2012. pii: bcr1120115225. doi: 10.1136/bcr.11.2011.5225.

15.

Subcutaneous electrocardiogram monitors and their field of view.

Arzbaecher R, Hampton DR, Burke MC, Garrett MC.

J Electrocardiol. 2010 Nov-Dec;43(6):601-5. doi: 10.1016/j.jelectrocard.2010.05.017. Epub 2010 Jul 27.

16.

Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.

Starke RM, Komotar RJ, Hwang BY, Hahn DK, Otten ML, Hickman ZL, Garrett MC, Sisti MB, Lavine SD, Meyers PM, Solomon RA, Connolly ES Jr.

Neurosurgery. 2010 Feb;66(2):343-8; discussion 348. doi: 10.1227/01.NEU.0000363599.72318.BA.

PMID:
20087134
17.

Treatment guidelines for cerebral arteriovenous malformation microsurgery.

Starke RM, Komotar RJ, Hwang BY, Fischer LE, Garrett MC, Otten ML, Connolly ES.

Br J Neurosurg. 2009 Aug;23(4):376-86. doi: 10.1080/02688690902977662. Review.

PMID:
19637008
18.

Elevated troponin levels are predictive of mortality in surgical intracerebral hemorrhage patients.

Garrett MC, Komotar RJ, Starke RM, Doshi D, Otten ML, Connolly ES.

Neurocrit Care. 2010 Apr;12(2):199-203. doi: 10.1007/s12028-009-9245-5. Epub 2009 Jul 21.

PMID:
19629759
19.

The complement cascade: new avenues in stroke therapy.

Komotar RJ, Starke RM, Arias EJ, Garrett MC, Otten ML, Merkow MB, Hassid B, Mocco J, Sughrue ME, Kim GH, Mack WJ, Ducruet AF, Connolly ES.

Curr Vasc Pharmacol. 2009 Jul;7(3):287-92. Review.

PMID:
19601853
20.

Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits.

Starke RM, Komotar RJ, Otten ML, Hahn DK, Fischer LE, Hwang BY, Garrett MC, Sciacca RR, Sisti MB, Solomon RA, Lavine SD, Connolly ES, Meyers PM.

Stroke. 2009 Aug;40(8):2783-90. doi: 10.1161/STROKEAHA.108.539775. Epub 2009 May 28.

21.

How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study.

Gago MF, Garrett MC, Fonseca MR, Rosas MJ, Simões MF, Vieira S, Botelho F.

J Neurol. 2009 Oct;256(10):1655-62. doi: 10.1007/s00415-009-5174-7. Epub 2009 May 27.

PMID:
19471849
22.

Synergistic neuroprotective effects of C3a and C5a receptor blockade following intracerebral hemorrhage.

Garrett MC, Otten ML, Starke RM, Komotar RJ, Magotti P, Lambris JD, Rynkowski MA, Connolly ES.

Brain Res. 2009 Nov 17;1298:171-7. doi: 10.1016/j.brainres.2009.04.047. Epub 2009 May 4.

23.

Clinical features, surgical treatment, and long-term outcome in adult patients with moyamoya disease. Clinical article.

Starke RM, Komotar RJ, Hickman ZL, Paz YE, Pugliese AG, Otten ML, Garrett MC, Elkind MS, Marshall RS, Festa JR, Meyers PM, Connolly ES Jr.

J Neurosurg. 2009 Nov;111(5):936-42. doi: 10.3171/2009.3.JNS08837.

24.

Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy.

Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Connolly ES.

J Crit Care. 2009 Sep;24(3):335-9. doi: 10.1016/j.jcrc.2008.10.015. Epub 2009 Feb 13.

PMID:
19327321
25.

The role of polyamine metabolism in neuronal injury following cerebral ischemia.

Kim GH, Komotar RJ, McCullough-Hicks ME, Otten ML, Starke RM, Kellner CP, Garrett MC, Merkow MB, Rynkowski M, Dash KA, Connolly S.

Can J Neurol Sci. 2009 Jan;36(1):14-9. Review.

PMID:
19294882
26.

Efficacy of lamina terminalis fenestration in reducing shunt-dependent hydrocephalus following aneurysmal subarachnoid hemorrhage: a systematic review. Clinical article.

Komotar RJ, Hahn DK, Kim GH, Starke RM, Garrett MC, Merkow MB, Otten ML, Sciacca RR, Connolly ES Jr.

J Neurosurg. 2009 Jul;111(1):147-54. doi: 10.3171/2009.1.JNS0821. Review.

PMID:
19284236
27.

The efficacy of direct extracranial-intracranial bypass in the treatment of symptomatic hemodynamic failure secondary to athero-occlusive disease: a systematic review.

Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Sciacca RR, Connolly ES.

Clin Neurol Neurosurg. 2009 May;111(4):319-26. doi: 10.1016/j.clineuro.2008.12.012. Epub 2009 Feb 7. Review.

PMID:
19201526
28.

The role of indirect extracranial-intracranial bypass in the treatment of symptomatic intracranial atheroocclusive disease.

Komotar RJ, Starke RM, Otten ML, Merkow MB, Garrett MC, Marshall RS, Elkind MS, Connolly ES.

J Neurosurg. 2009 May;110(5):896-904. doi: 10.3171/2008.9.JNS17658.

PMID:
19199456
29.

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone-a critical review.

Komotar RJ, Otten ML, Garrett MC, Anderson RC.

Clin Med Oncol. 2009 Mar 4;3:13-4. No abstract available.

30.

The role of complement in stroke therapy.

Komotar RJ, Kim GH, Otten ML, Hassid B, Mocco J, Sughrue ME, Starke RM, Mack WJ, Ducruet AF, Merkow MB, Garrett MC, Connolly ES.

Adv Exp Med Biol. 2008;632:23-33. Review.

PMID:
19025111
31.

Radiographic and clinical predictors of hemodynamic insufficiency in patients with athero-occlusive disease.

Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Connolly ES.

J Stroke Cerebrovasc Dis. 2008 Nov-Dec;17(6):340-3. doi: 10.1016/j.jstrokecerebrovasdis.2008.04.005. Review.

PMID:
18984424
32.

The incidence of heparin-induced thrombocytopenia Type II in patients with subarachnoid hemorrhage treated with heparin versus enoxaparin.

Kim GH, Hahn DK, Kellner CP, Komotar RJ, Starke R, Garrett MC, Yao J, Cleveland J, Mayer SA, Connolly ES.

J Neurosurg. 2009 Jan;110(1):50-7. doi: 10.3171/2008.3.17480.

PMID:
18976056
33.

C3a receptor antagonist attenuates brain injury after intracerebral hemorrhage.

Rynkowski MA, Kim GH, Garrett MC, Zacharia BE, Otten ML, Sosunov SA, Komotar RJ, Hassid BG, Ducruet AF, Lambris JD, Connolly ES.

J Cereb Blood Flow Metab. 2009 Jan;29(1):98-107. doi: 10.1038/jcbfm.2008.95. Epub 2008 Aug 27.

34.

Plasma acrolein levels and their association with delayed ischemic neurological deficits following aneurysmal subarachnoid haemorrhage: a pilot study.

Garrett MC, McCullough-Hicks ME, Kim GH, Komotar RJ, Kellner CP, Hahn DK, Otten ML, Rynkowski MA, Merkow MB, Starke RM, Connolly ES.

Br J Neurosurg. 2008 Aug;22(4):546-9. doi: 10.1080/02688690802072945.

PMID:
18686065
35.

Does timing and dosage of levodopa modify drug-induced dyskinesias and motor fluctuations? A retrospective analysis.

Garrett MC, Rosas MJ, Simões F, Vieira S, Costa M.

Parkinsonism Relat Disord. 1998 Aug;4(2):99-102.

PMID:
18591097
36.

Elevation of monocyte chemoattractant protein-1 in patients experiencing neurocognitive decline following carotid endarterectomy.

Mack WJ, Ducruet AF, Hickman ZL, Zurica J, Starke RM, Garrett MC, Komotar RJ, Quest DO, Solomon RA, Heyer EJ, Sander Connolly E.

Acta Neurochir (Wien). 2008 Aug;150(8):779-84; discussion 784. doi: 10.1007/s00701-008-1618-6. Epub 2008 Jun 23.

37.

A comprehensive review of radiosurgery for cerebral arteriovenous malformations: outcomes, predictive factors, and grading scales.

Starke RM, Komotar RJ, Hwang BY, Fischer LE, Otten ML, Merkow MB, Garrett MC, Isaacson SR, Connolly ES Jr.

Stereotact Funct Neurosurg. 2008;86(3):191-9. doi: 10.1159/000126945. Epub 2008 Apr 18. Review.

PMID:
18421250
38.

The extracranial-intracranial bypass trial: implications for future investigations.

Garrett MC, Komotar RJ, Merkow MB, Starke RM, Otten ML, Connolly ES.

Neurosurg Focus. 2008;24(2):E4. doi: 10.3171/FOC/2008/24/2/E4. Review.

PMID:
18275299
39.

A mouse model of intracerebral hemorrhage using autologous blood infusion.

Rynkowski MA, Kim GH, Komotar RJ, Otten ML, Ducruet AF, Zacharia BE, Kellner CP, Hahn DK, Merkow MB, Garrett MC, Starke RM, Cho BM, Sosunov SA, Connolly ES.

Nat Protoc. 2008;3(1):122-8. doi: 10.1038/nprot.2007.513.

PMID:
18193028
40.

Pupillary reactivity upon hospital admission predicts long-term outcome in poor grade aneurysmal subarachnoid hemorrhage patients.

Mack WJ, Hickman ZL, Ducruet AF, Kalyvas JT, Garrett MC, Starke RM, Komotar RJ, Lavine SD, Meyers PM, Mayer SA, Connolly ES.

Neurocrit Care. 2008;8(3):374-9.

PMID:
18058256
41.

Neurologic assessment of somatosensory dysfunction following an experimental rodent model of cerebral ischemia.

Komotar RJ, Kim GH, Sughrue ME, Otten ML, Rynkowski MA, Kellner CP, Hahn DK, Merkow MB, Garrett MC, Starke RM, Connolly ES.

Nat Protoc. 2007;2(10):2345-7.

PMID:
17947976
42.

Early plasma complement C3a levels correlate with functional outcome after aneurysmal subarachnoid hemorrhage.

Mack WJ, Ducruet AF, Hickman ZL, Garrett MC, Albert EJ, Kellner CP, Mocco J, Connolly ES Jr.

Neurosurgery. 2007 Aug;61(2):255-60; discussion 260-1.

PMID:
17762737
43.

Stimulation of human anti-viral CD8+ cytolytic T lymphocytes by dendritic cells.

Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM.

Adv Exp Med Biol. 1995;378:375-9. Review. No abstract available.

PMID:
8526097
44.

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Bhardwaj N, Bender A, Gonzalez N, Bui LK, Garrett MC, Steinman RM.

J Clin Invest. 1994 Aug;94(2):797-807.

45.

Role of p67-phox SH3 domains in assembly of the NADPH oxidase system.

de Mendez I, Garrett MC, Adams AG, Leto TL.

J Biol Chem. 1994 Jun 10;269(23):16326-32.

46.
48.

Characterization of neutrophil NADPH oxidase factors p47-phox and p67-phox from recombinant baculoviruses.

Leto TL, Garrett MC, Fujii H, Nunoi H.

J Biol Chem. 1991 Oct 15;266(29):19812-8.

50.

Supplemental Content

Loading ...
Support Center